Skip to main content
. 2024 Feb 10;14(2):e074541. doi: 10.1136/bmjopen-2023-074541

Figure 1.

Figure 1

(A) Timeline of high-density lipoprotein cholesterol (HDL-C) levels in patients detected anthracycline-induced subclinical cardiotoxicity (AISC) at four time points. 12 patients were detected AISC at the end of the third cycle of chemotherapy. 7 patients were detected AISC at the end of the sixth cycle of chemotherapy. 3 patients were detected AISC at 6 months after treatment completion. 2 patients were detected AISC at 12 months after treatment completion. (B) Timeline of HDL-C levels of patients without AISC.